ArticleThe Lancet regional health. Southeast Asia2025
Distribution of government health financing benefits among women who delivered in public institutions in Bangladesh: a nationally representative cross-sectional study.
Article in The Lancet regional health. Southeast Asia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Toward SDG 3 in a developing nation: the role of health expenditure, financial development, and population growth in shaping health outcomes.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Equitable access to institutional delivery care is crucial for reducing maternal mortality. Although Bangladesh has made progress in this regard, significant challenges persist in achieving equitable access to institutional delivery care, particularly for economically disadvantaged populations. The objective of this study was to investigate the distribution of public health financing benefits among women who delivered in public facilities in Bangladesh. Methods: This study was conducted based on the data from the Bangladesh Demographic and Health Survey (BDHS) 2022, which includes a sample of 3360 women (age 15-49 years) who had a history of institutional delivery during two years preceding the survey. Descriptive and econometric analyses, including Benefit Incidence Analysis (BIA), Concentration Curves (CC), and Concentration Indices (CIX), were employed to assess the distribution of public subsidies for delivery care among different socio-economic groups. Socioeconomic inequality in utilisation of delivery care services was evaluated using concentration curves, while BIA estimated the distribution of public healthcare benefits across wealth quintiles. Logistic regression was used to determine the factors associated with distress financing-whether the household of the women had to sell their assets or had to resort of borrowing to avail services. Findings: Among the poorest quintile, 38% utilised public facilities, compared to 17% of the women with highest income. The concentration curve for public facility use indicated a pro-poor distribution (CIX -0.031). BIA revealed that the poorest quintile received 24.5% of public subsidies, whereas the wealthiest quintile received 13.7%. However, in tertiary care facilities and for caesarean delivery, the wealthiest group benefitted the most, receiving 23.5% and 26% of the subsidies, respectively. Odds of distress financing was significantly higher among women from poorer or poorest households compared to the richest group (aOR 4.35, 95% CI 3.16-6.03 for poorest and aOR 2.74, 95% CI 2.00-3.77 for poorer). Interpretation: Public health subsidies in Bangladesh equitably benefit women with lower income, though inequities remain, particularly in tertiary care facilities and for caesarean deliveries. Despite this, women with lower income are more vulnerable to distress financing for delivery care. Funding: None.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.